Formulation Development
Innovative, Science-Driven Formulation Strategies for Topical & Transmucosal Drug Products
Comprehensive Formulation Development Services
At MedPharm, we guide clients through every stage of formulation development, from pre-formulation studies to commercial viability. We ensure that products meet regulatory requirements, enhance patient compliance, and optimize therapeutic performance.
At MedPharm, our Formulation Development services provide a rigorous, scientifically driven approach to developing safe, effective, and scalable pharmaceutical formulations. Leveraging Quality by Design (QbD) principles, we integrate API characterization, pre-formulation studies, in silico modeling, and in vitro testing to optimize drug performance and mitigate risk before reaching costly clinical phases.
Data You Can Trust. Insights That Move You Forward.
At MedPharm, our Analytical Services are not just a checkpoint—they are a strategic cornerstone of successful pharmaceutical development. We specialize in topical and transdermal drug products, providing analytical and bioanalytical testing to support every phase of the product lifecycle, from early-stage formulation to clinical development and commercial release.
Whether you require custom method development, stability support, or bioanalytical insights, MedPharm delivers high-quality, regulatory-compliant data to inform your decisions and accelerate your progress.
Accelerating Discovery Through Smart, Strategic Development
At MedPharm, our Early-Stage Services are designed to build a strong foundation for success—guiding drug candidates from initial discovery through preclinical and Phase I development. We bring deep expertise in formulation science, process development, and analytical testing to help innovators de-risk early development, optimize their products, and accelerate progress toward clinical milestones.
With specialized focus on non-oral, non-invasive delivery routes, we offer comprehensive, phase-appropriate strategies that align scientific innovation with regulatory readiness, ensuring a seamless path from molecule to first-in-human studies.
Scaling, Optimizing, and Delivering for Clinical and Commercial Success
MedPharm’s Late-Stage Services are designed to guide drug products through the most critical phases of development: Phase II, Phase III, and preparation for commercial launch. As your product advances, the need for process robustness, regulatory compliance, and commercial scalability becomes paramount—and that’s where MedPharm excels.
We combine scientific rigor with real-world manufacturing and regulatory expertise to ensure late-stage programs are executed efficiently, with a clear path toward market readiness and sustained success.
Supplying Innovation, One Dose at a Time
At MedPharm, we recognize that clinical supply goes beyond logistics—it’s a vital component in proving the viability, safety, and efficacy of your drug product. Our Clinical Supply Services provide comprehensive support for topical and transdermal clinical programs, ensuring that your investigational therapies are manufactured, tested, and delivered with precision and compliance.
Whether you’re preparing for a Phase I study or finalizing your registration batches, MedPharm delivers clinical materials with the care, speed, and regulatory readiness that high-stakes trials require.
From Market Launch to Lifecycle Management
At MedPharm, our Commercial Services are designed to support your product well beyond clinical success. We offer full-scale commercial manufacturing, quality assurance, packaging, and supply chain solutions to ensure your therapies consistently meet the highest regulatory and market expectations.
With GMP-certified facilities, proven regulatory expertise, and a flexible manufacturing platform, we help pharmaceutical companies seamlessly transition their products from late-stage development to commercial launch—and sustain product excellence throughout the lifecycle.
